How to Win Over Value Analysis Committees: A Strategic Playbook

By Joshua Dunn, Founder · March 1, 2026 · 9 min read · Sales Strategies

Understanding the VAC's Perspective

Value analysis committees exist because hospitals cannot afford to adopt every new product that a sales rep brings through the door. VACs serve as the critical filter between clinical interest and institutional commitment. As a former VAC chair, I can tell you that the majority of product submissions fail not because the product is bad, but because the presentation does not address what the committee needs to see. Understanding the VAC's perspective is the first step to earning approval.

Committee reviewing presentation
A well-prepared VAC presentation addresses clinical, financial, and operational concerns simultaneously.

What the VAC Evaluates

Every VAC has its own process, but most evaluate products against four core pillars:

  • Clinical value: Does this product improve patient outcomes compared to current alternatives? Provide peer-reviewed clinical data, not just manufacturer marketing claims.
  • Financial impact: What is the total cost of adoption, including product cost, training, workflow changes, and any necessary equipment? How does this compare to current spend in the category?
  • Operational feasibility: Can the facility operationally integrate this product? Consider storage requirements, sterilization processes, staff training needs, and supply chain logistics.
  • Risk assessment: What are the patient safety implications? Is there a documented adverse event history? Are there any FDA warnings or recalls?

Preparing Your VAC Submission

A winning VAC submission includes specific elements that committees expect to see:

  1. Product data sheet: Technical specifications, regulatory status, and clinical indications in a concise one-page format.
  2. Clinical evidence summary: Two to three peer-reviewed studies demonstrating clinical superiority or equivalence. Include sample sizes, study design, and key outcomes.
  3. Cost-benefit analysis: A detailed comparison of your product's total cost against the current product, including volume projections and any rebate or discount programs.
  4. Implementation plan: A timeline for training, trial evaluation, and full rollout that shows you have thought through the operational details.
  5. Physician champion letter: A letter from the requesting physician explaining the clinical rationale for the product. This carries significant weight.
Financial analysis documents
Cost-benefit analysis is often the deciding factor in VAC deliberations.

Common Mistakes That Kill VAC Approvals

Avoid these frequent errors that cause VAC rejections: submitting without a physician champion, providing marketing brochures instead of clinical data, failing to include a cost analysis, not understanding the facility's current product usage, and requesting approval without offering a trial period. Committees are skeptical of products that come without transparent clinical and financial data, and they are wary of reps who push for immediate adoption without a structured evaluation process.

Win the VAC and you win the account. Treat every submission as a business proposal, not a sales pitch, and you will dramatically increase your approval rate.

Related articles

Back to all articles